Inotiv Modernizes Compliance Workflows with Certinal’s Unified Digital Transaction Management Platform
From legacy friction to intelligent flow: Inotiv upgrades approval infrastructure with speed, security, and scale
Wilmington, Delaware – December 8, 2025 — Inotiv, a leading contract research organization (CRO) specializing in nonclinical and analytical drug discovery and development services, has selected Certinal to power its next-generation Digital Transaction Management (DTM) stack — replacing a legacy eSignature solution that no longer met its needs.
For a highly regulated organization operating in a time-sensitive, audit-heavy environment, friction in approvals can mean delay in impact. Inotiv needed more than incremental change. It required a single, unified platform that could intelligently manage internal and external signature workflows, integrate with its existing systems, and accelerate the pace of business — all while staying FDA 21 CFR Part 11 compliant.
“The shift to Certinal wasn’t just about replacing an eSignature tool — it was about rethinking how digital approvals should work in a modern, regulated enterprise,” said Kristi Allen, Vice President, Global Procurement at Inotiv.
“We were impressed with how fast the Certinal team executed the migration. Within weeks, we had a compliant, integrated system that now anchors both our internal and external approval processes.”
With Certinal in place, Inotiv transitioned from its legacy platform with zero operational downtime. The team now benefits from a single workflow layer that powers both internal and external transaction management — procured and priced separately to reflect distinct compliance needs. Certinal’s seamless integration with iContract has enabled a smooth digital procurement experience, especially for managing complex vendor contracts. Meanwhile, internal approvals — ranging from HR documents and NDAs to operational policies — have also been streamlined into a mobile-friendly, audit-ready environment.
Primary use cases at Inotiv include procurement contracts integrated with iContract, internal documentation such as offer letters and policy approvals, and external agreements like vendor partnerships and research collaborations. Certinal’s API-first architecture enabled rapid integration with Inotiv’s existing tech stack, including HubSpot and MobileForce, helping the organization scale quickly without custom engineering work.
“Inotiv is exactly the kind of enterprise we built Certinal for — fast-moving, heavily regulated, and unwilling to compromise on user experience or compliance,” said Philemon Raju S, Chief Executive Officer, Certinal.
“Our goal is to take the ‘transaction’ out of digital transactions — by turning approvals into invisible, intelligent flows.”
About Inotiv
Inotiv, Inc. is a leading contract research organization dedicated to providing non-clinical and analytical drug discovery and development services and research models and related products and services. The Company’s products and services focus on bringing new drugs and medical devices through the discovery and preclinical phases of development, all while increasing efficiency, improving data, and reducing the cost of taking new drugs and medical devices to market. Inotiv is committed to supporting discovery and development objectives as well as helping researchers realize the full potential of their critical R&D projects, all while working together to build a healthier and safer world. Further information about Inotiv can be found here: www.inotiv.com
About Certinal
Certinal delivers an enterprise-grade Unified Digital Transaction Management solution trusted in 80+ countries. Built for security, usability, and compliance, Certinal empowers large organizations with intelligent eSignature and eConsent capabilities that meet global, regional, and industry-specific regulations. Recognized as a Leader in IDC MarketScape 2023 and a Strong Performer in Gartner’s Voice of the Customer, Certinal is the only eSignature provider to earn Gartner’s Customer First Badge and has achieved the fastest entry into Gartner’s Market Guide for Electronic Signatures. With 11 patents filed and 2 granted, Certinal continues to push the boundaries of innovation, supported by an exceptional Net Promoter Score (NPS) of 85.32. Learn more at www.certinal.com
Ankit Aggarwal
Associate Director – Marketing, Certinal